Skip to main content
HROW $30.07 -0.92%
HROW logo
HROW · Harrow, Inc.
Track HROW — free
$30.07 -0.28 (-0.92%)
Market Cap
$1.24B
Shares
37.49M
Volume · Oct 7 102.44K Avg daily vol (3M) 556.37K
All webcasts

Earnings call · FY2025 Q2

Harrow, Inc. (HROW) Q2 2025 Earnings Call

Concluded Aug 11, 2025
Aug 11, 2025 0 turns
Period
FY2025 Q2
Runtime
—
Sources
2 artifacts

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Revenue growth and guidance 78 VEVYE product momentum 57 IHEEZO retina growth 54 TRIESENCE opportunity 39 Strategic acquisitions (BYQLOVI and Samsung biosimilars) 29 Specialty pharmacy and access partnerships 12

Management tone

Confident

Net tone +70 · low hedging

Grounding quotes
  • “we are positioned to achieve our guidance targets”
  • “we do not anticipate a slowdown in this momentum”
  • “I have high expectations for it, especially as we enter the ocular inflammation market, which represents a significant opportunity for us”
  • “we will provide more details during the Investor and Analyst Day”

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $63.74M +30.2% YoY
Diluted EPS $0.13
Gross margin 74.5% +0.1 pp YoY
Net income $5.00M

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document